Cargando…

Cancer cell intrinsic TIM-3 induces glioblastoma progression

Glioblastoma (GBM) is identified to share common signal pathways between glioma and immune cells. Here, we find that T cell immunoglobulin domain and mucin domain protein 3 (TIM-3) is one of the most common co-inhibitory immune checkpoints in GBM shared by tumor and non-tumor cells. Glioma cell-intr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Qing, Shen, Shuai, Guan, Gefei, Zhu, Chen, Zou, Cunyi, Cao, Jingyuan, Cheng, Wen, Xu, Xiaoyan, Yu, Juanhan, Lin, Zhiguo, Wang, Guoli, Chen, Ling, Cheng, Peng, Wu, Anhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618784/ https://www.ncbi.nlm.nih.gov/pubmed/36325060 http://dx.doi.org/10.1016/j.isci.2022.105329

Ejemplares similares

IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma
por: Zhu, Chen, et al.
Publicado: (2020)

Dual role of ARPC1B in regulating the network between tumor-associated macrophages and tumor cells in glioblastoma
por: Liu, Tianqi, et al.
Publicado: (2022)

CD48 is a key molecule of immunomodulation affecting prognosis in glioma
por: Zou, Cunyi, et al.
Publicado: (2019)

Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy
por: Shen, Shuai, et al.
Publicado: (2020)

Secretory Pathway Kinase FAM20C, a Marker for Glioma Invasion and Malignancy, Predicts Poor Prognosis of Glioma
por: Du, Shaonan, et al.
Publicado: (2020)

Molecular profiling identifies distinct subtypes across TP53 mutant tumors
por: Chen, Xin, et al.
Publicado: (2022)

The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma
por: Han, Yunhe, et al.
Publicado: (2021)

Long non-coding RNA, HOTAIRM1, promotes glioma malignancy by forming a ceRNA network
por: Liang, Qingyu, et al.
Publicado: (2019)

LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT
por: Zhang, Qing, et al.
Publicado: (2020)

Characterization of an endoplasmic reticulum stress‐related signature to evaluate immune features and predict prognosis in glioma
por: Zhang, Qing, et al.
Publicado: (2021)

Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner
por: Wu, Jianqi, et al.
Publicado: (2022)

Tim-3 Expression and MGMT Methylation Status Association With Survival in Glioblastoma
por: Zhang, Ji, et al.
Publicado: (2020)

DIPG-04. TUMOR CELL-INTRINSIC TIM-3 PROMOTES DIFFUSE INTRINSIC PONTINE GLIOMA TUMORIGENESIS
por: Ausejo-Mauleon, Iker, et al.
Publicado: (2023)

Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma
por: Yan, Zihao, et al.
Publicado: (2021)

ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL
por: Wang, Yulin, et al.
Publicado: (2018)

Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma
por: Liang, Qingyu, et al.
Publicado: (2020)

Altered expression of Tim family molecules and an imbalanced ratio of Tim-3 to Tim-1 expression in patients with type 1 diabetes
por: Liu, Yikai, et al.
Publicado: (2022)

Similarity in Shape Dictates Signature Intrinsic Dynamics Despite No Functional Conservation in TIM Barrel Enzymes
por: Tiwari, Sandhya P., et al.
Publicado: (2016)

Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies
por: Phong, Binh, et al.
Publicado: (2016)

Tim Burton /
por: Marcos Arza, Marcos
Publicado: (2007)

Tim Lou
por: Lou, Hou Keong
Publicado: (2009)

Down-Regulation of Tim-3 in Monocytes and Macrophages in Plasmodium Infection and Its Association with Parasite Clearance
por: Hou, Nan, et al.
Publicado: (2017)

Tim1 and Tim3 are not essential for experimental allergic asthma
por: Barlow, J L, et al.
Publicado: (2011)

The effects of Tim-3 activation on T-cells in gastric cancer progression
por: Yu, Jiangtao, et al.
Publicado: (2019)

A novel antibody targeting TIM-3 resulting in receptor internalization for cancer immunotherapy
por: Kuang, Zhihui, et al.
Publicado: (2020)

Interrogating glioma-M2 macrophage interactions identifies Gal-9/Tim-3 as a viable target against PTEN-null glioblastoma
por: Ni, Xiangrong, et al.
Publicado: (2022)

TIM-Finder: A new method for identifying TIM-barrel proteins
por: Si, Jing-Na, et al.
Publicado: (2009)

Mertk Interacts with Tim-4 to Enhance Tim-4-Mediated Efferocytosis
por: Moon, Byeongjin, et al.
Publicado: (2020)

TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory
por: Ausejo-Mauleon, Iker, et al.
Publicado: (2023)

A Risk Classification System With Five-Gene for Survival Prediction of Glioblastoma Patients
por: Wang, Yulin, et al.
Publicado: (2019)

Tim-3 expression on peripheral T cell subsets correlates with disease progression in hepatitis B infection
por: Wu, Wei, et al.
Publicado: (2011)

Tim-3 is upregulated in human colorectal carcinoma and associated with tumor progression
por: Yu, Muming, et al.
Publicado: (2017)

Interview with Tim Smith
por: Smith, Tim, et al.
Publicado: (2019)

Tim Berners-Lee
Publicado: (2004)

Come on, Sir Tim!
Publicado: (2009)

Inhibition of TIM‐4 protects against cerebral ischaemia‐reperfusion injury
por: Zheng, Lifang, et al.
Publicado: (2019)

Suppression of Allograft Rejection by Tim-1-Fc through Cross-Linking with a Novel Tim-1 Binding Partner on T Cells
por: Xiao, Liang, et al.
Publicado: (2011)

Divergent Small Tim Homologues Are Associated with TbTim17 and Critical for the Biogenesis of TbTim17 Protein Complexes in Trypanosoma brucei
por: Smith, Joseph T., et al.
Publicado: (2018)

A mutagenesis analysis of Tim50, the major receptor of the TIM23 complex, identifies regions that affect its interaction with Tim23
por: Dayan, Dana, et al.
Publicado: (2019)

Plasma IGFBP-2 Levels after Postoperative Combined Radiotherapy and Chemotherapy Predict Prognosis in Elderly Glioblastoma Patients
por: Han, Sheng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_332g0g212el5lmr14kk10om2bh